Davis Polk advised Auna S.A.A. in connection with its Rule 144A/Regulation S offering of $300 million aggregate principal amount of its 6.500% senior notes due 2025. The notes are…
Davis Polk advised the sales agents in connection with an SEC-registered at-the-market offering by BioNTech SE of its ordinary shares represented by American depositary shares for up to an…
Davis Polk advised the joint book-running managers and the initial purchasers in a Rule 144A/Regulation S offering of $250 million principal amount of 3.000% senior secured notes due…
Davis Polk advised Grayscale Investments, LLC, as sponsor, in connection with the registration of the common units of fractional undivided beneficial interest (“Shares”) of Grayscale…
Davis Polk advised Gilead Sciences, Inc. in connection with an SEC-registered offering of $7.25 billion aggregate principal amount of senior notes, consisting of (i) $500 million aggregate…
Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A/Regulation S offering by Quicken Loans, LLC of $750 million aggregate principal amount of its…
Davis Polk advised the joint book-running managers in connection with a registered offering by Eli Lilly and Company of $1.1 billion aggregate principal amount of senior notes, consisting…
Davis Polk advised the joint book-running managers and the initial purchasers in a Rule 144A/Regulation S offering of $550 million principal amount of 3.000% senior secured notes due…
Davis Polk advised the joint book-running managers and the initial purchasers in Rule 144A/Regulation S offerings of €325 million principal amount of 2.750% senior secured notes due 2028…